• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性 Neprilysin 与糖尿病的关系:一项前瞻性纵向研究的结果。

Association between soluble neprilysin and diabetes: Findings from a prospective longitudinal study.

机构信息

Department of Cardiology, The First Affiliated Hospital of Soochow University, Suzhou, China.

Department of Epidemiology, School of Public Health, Medical College of Soochow University, Suzhou, China.

出版信息

Front Endocrinol (Lausanne). 2023 Mar 30;14:1143590. doi: 10.3389/fendo.2023.1143590. eCollection 2023.

DOI:10.3389/fendo.2023.1143590
PMID:37065764
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10100928/
Abstract

BACKGROUND

The potential role of neprilysin (NEP) in glucose metabolism has been found by basic studies but lacks population evidence. The objective of this study was to examine the association between serum NEP and diabetes in Chinese adults.

METHODS

In a prospective longitudinal cohort study - the Gusu cohort (n=2,286, mean age: 52 years, 61.5% females), the cross-sectional, longitudinal, and prospective associations between serum NEP and diabetes were systemically examined by logistic regression adjusting for conventional risk factors. Serum NEP was measured at baseline using commercial ELISA assays. Fasting glucose was repeatedly measured 4 years apart.

RESULTS

The cross-sectional analysis found a positive association between serum NEP and fasting glucose at baseline (β=0.08, =0.004 for log-transformed NEP). This association persisted after controlling for the dynamic risk profiles during follow-up (β=0.10, =0.023 for log-transformed NEP). The prospective analysis found that a higher level of serum NEP at baseline was associated with a higher risk of diabetes during follow-up (OR=1.79, =0.039 for log-transformed NEP).

CONCLUSIONS

Serum NEP was not only associated with prevalent diabetes but also predicted the future risk of diabetes development in Chinese adults, independent of many behavioral and metabolic factors. Serum NEP may be a predictor and even a new therapeutic target for diabetes. However, the casualty and mechanisms of NEP in the development of diabetes require further investigation.

摘要

背景

基础研究发现,脑啡肽酶(NEP)在葡萄糖代谢中具有潜在作用,但缺乏人群证据。本研究旨在探讨中国成年人血清 NEP 与糖尿病之间的关系。

方法

在一项前瞻性纵向队列研究——姑苏队列(n=2286,平均年龄 52 岁,61.5%为女性)中,通过逻辑回归调整常规危险因素,系统地检验了血清 NEP 与糖尿病之间的横断面、纵向和前瞻性关联。使用商业 ELISA 检测试剂盒在基线时测量血清 NEP。空腹血糖在 4 年的时间间隔内重复测量。

结果

横断面分析发现,基线时血清 NEP 与空腹血糖呈正相关(β=0.08,=0.004,用于 log 转换的 NEP)。在随访期间控制动态风险特征后,这种关联仍然存在(β=0.10,=0.023,用于 log 转换的 NEP)。前瞻性分析发现,基线时较高的血清 NEP 水平与随访期间糖尿病的风险增加相关(OR=1.79,=0.039,用于 log 转换的 NEP)。

结论

血清 NEP 不仅与现患糖尿病相关,而且独立于许多行为和代谢因素,预测中国成年人未来发生糖尿病的风险。血清 NEP 可能是糖尿病的预测指标,甚至是新的治疗靶点。然而,NEP 在糖尿病发展中的因果关系和机制需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c311/10100928/8cda8f2c425f/fendo-14-1143590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c311/10100928/04d1f80be9df/fendo-14-1143590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c311/10100928/b1162e8e5bf0/fendo-14-1143590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c311/10100928/8cda8f2c425f/fendo-14-1143590-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c311/10100928/04d1f80be9df/fendo-14-1143590-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c311/10100928/b1162e8e5bf0/fendo-14-1143590-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c311/10100928/8cda8f2c425f/fendo-14-1143590-g003.jpg

相似文献

1
Association between soluble neprilysin and diabetes: Findings from a prospective longitudinal study.可溶性 Neprilysin 与糖尿病的关系:一项前瞻性纵向研究的结果。
Front Endocrinol (Lausanne). 2023 Mar 30;14:1143590. doi: 10.3389/fendo.2023.1143590. eCollection 2023.
2
Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes.2 型糖尿病患者尿液中的血管紧张素转换酶 2 和 Neprilysin 增加。
Am J Physiol Renal Physiol. 2018 Aug 1;315(2):F263-F274. doi: 10.1152/ajprenal.00565.2017. Epub 2018 Mar 21.
3
Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena.脑啡肽酶和脑啡肽酶抑制剂对糖代谢的影响:争议点和有前途的领域。
J Diabetes. 2023 May;15(5):397-408. doi: 10.1111/1753-0407.13389. Epub 2023 Apr 19.
4
Neprilysin Deficiency Is Associated With Expansion of Islet β-Cell Mass in High Fat-Fed Mice.脑啡肽酶缺乏与高脂肪喂养小鼠胰岛β细胞质量的扩张有关。
J Histochem Cytochem. 2018 Jul;66(7):523-530. doi: 10.1369/0022155418765164. Epub 2018 Mar 19.
5
The changing features of serum adropin, copeptin, neprilysin and chitotriosidase which are associated with vascular endothelial function in type 2 diabetic retinopathy patients.2 型糖尿病视网膜病变患者与血管内皮功能相关的血清 adropin、copeptin、neprilysin 和 chitotriosidase 的变化特征。
J Diabetes Complications. 2020 Nov;34(11):107686. doi: 10.1016/j.jdiacomp.2020.107686. Epub 2020 Jul 23.
6
The association of morning serum cortisol with glucose metabolism and diabetes: The Jackson Heart Study.晨血清皮质醇与葡萄糖代谢和糖尿病的关系:杰克逊心脏研究。
Psychoneuroendocrinology. 2019 May;103:25-32. doi: 10.1016/j.psyneuen.2018.12.237. Epub 2018 Dec 27.
7
Neprilysin in the Cerebrospinal Fluid and Serum of Patients Infected With HIV1-Subtypes C and B.HIV1 型 C 和 B 亚型感染患者脑脊液和血清中的 Neprilysin。
J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):248-256. doi: 10.1097/QAI.0000000000001666.
8
Association Between Serum Furin and Fasting Glucose: A Cross-Sectional Study in Chinese Adults.血清弗林与空腹血糖的相关性:中国成年人的横断面研究。
Front Endocrinol (Lausanne). 2022 Jan 3;12:781890. doi: 10.3389/fendo.2021.781890. eCollection 2021.
9
Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels.高脂喂养的中性内肽酶缺陷小鼠血糖改善与二肽基肽酶-4(DPP-4)活性降低及活性胰高血糖素样肽-1(GLP-1)水平升高有关。
Diabetologia. 2017 Apr;60(4):701-708. doi: 10.1007/s00125-016-4172-4. Epub 2016 Dec 8.
10
Renin-Angiotensin-Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA.肾素-血管紧张素-醛固酮系统、糖代谢与 2 型糖尿病发病风险:MESA 研究。
J Am Heart Assoc. 2018 Sep 4;7(17):e009890. doi: 10.1161/JAHA.118.009890.

本文引用的文献

1
Real-world experience of angiotensin receptor neprilysin inhibitor on the glucose-lowering effect.血管紧张素受体脑啡肽酶抑制剂的降糖作用的真实世界经验。
Sci Rep. 2022 Jun 11;12(1):9703. doi: 10.1038/s41598-022-13366-z.
2
Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with -cell dysfunction.在胰岛β细胞功能障碍的小鼠中,抑制脑啡肽酶可通过 GLP-1R 信号改善静脉内而非口服葡萄糖介导的胰岛素分泌。
Am J Physiol Endocrinol Metab. 2022 Mar 1;322(3):E307-E318. doi: 10.1152/ajpendo.00234.2021. Epub 2022 Feb 7.
3
Natriuretic Peptides and Risk of Type 2 Diabetes: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
利钠肽与 2 型糖尿病风险:来自欧洲心血管风险评估生物标志物(BiomarCaRE)联盟的结果。
Diabetes Care. 2021 Nov;44(11):2527-2535. doi: 10.2337/dc21-0811. Epub 2021 Sep 14.
4
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
5
Neprilysin expression and functions in development, ageing and disease.脑啡肽酶表达及其在发育、衰老和疾病中的功能。
Mech Ageing Dev. 2020 Dec;192:111363. doi: 10.1016/j.mad.2020.111363. Epub 2020 Sep 26.
6
Soluble neprilysin: A versatile biomarker for heart failure, cardiovascular diseases and diabetic complications-A systematic review.可溶性 Neprilysin:心力衰竭、心血管疾病和糖尿病并发症的多功能生物标志物——系统综述。
Indian Heart J. 2020 Jan-Feb;72(1):14-19. doi: 10.1016/j.ihj.2020.01.006. Epub 2020 Feb 4.
7
2. Classification and Diagnosis of Diabetes: .2. 糖尿病的分类和诊断: 。
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31. doi: 10.2337/dc20-S002.
8
Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.沙库巴曲缬沙坦在心力衰竭射血分数谱中的应用。
Circulation. 2020 Feb 4;141(5):352-361. doi: 10.1161/CIRCULATIONAHA.119.044586. Epub 2019 Nov 17.
9
Membrane metallo-endopeptidase (Neprilysin) regulates inflammatory response and insulin signaling in white preadipocytes.膜金属肽酶(Neprilysin)调节白色前体脂肪细胞中的炎症反应和胰岛素信号转导。
Mol Metab. 2019 Apr;22:21-36. doi: 10.1016/j.molmet.2019.01.006. Epub 2019 Jan 25.
10
Augmentation of glucagon-like peptide-1 receptor signalling by neprilysin inhibition: potential implications for patients with heart failure.抑制脑啡肽酶增强胰高血糖素样肽-1 受体信号:对心力衰竭患者的潜在影响。
Eur J Heart Fail. 2018 Jun;20(6):973-977. doi: 10.1002/ejhf.1185. Epub 2018 Mar 30.